samedan logo
 
 
spacer
home > pmps > winter 2020 > pharmapack foreword
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Pharmapack Foreword



It’s a really exciting time for the industry as the range of innovations and new market entrants proliferate, which is redefining the art of the possible for drug delivery devices and pharmaceutical packaging. With these exciting market conditions as our backdrop, we are pleased to partner with PMPS to bring you this special feature focusing on drug delivery and packaging. You will get insights into the latest developments in this space as well as a preview of Pharmapack Europe 2020, taking place on the 5-6 February 2019 at the Paris Expo, Porte de Versailles, France.

The event provides invaluable networking, an exhibition, and the latest insights in the pharma packaging and drug delivery industries. This year, Pharmapack will host over 410 exhibitors and 5,500 attendees from more than 100 unique countries.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Silvia Forroova, Brand Director
Print this page
Send to a friend
Privacy statement
News and Press Releases

Grupo NotreDame Intermédica (GNDI) of Brazil enhances patient care and improves patient access to leading-edge medications by joining Clinerion’s global network of hospital partners on Patient Network Explorer

Grupo NotreDame Intermédica (GNDI) is the largest healthcare operator in Brazil, with 6.4 million members. Founded in 1968, it is a pioneer in preventive medicine. GNDI has a wide offer, comprising 29 hospitals, 88 clinical centers, 23 autonomous emergency rooms, 15 preventive medicine centers and 2 health centers exclusively dedicated to the over-fifties.
More info >>

White Papers

Is Your Biobank Ready for the Challenge of Biomarker-based Research?

BioFortis

Targeted and personalized studies with well-defined patient segmentation biomarkers are becoming the norm in clinical trials. This increased interest in molecular biomarker studies necessitates a rigor and sophistication in sample management within the clinical trial context that is often not supported either by traditional clinical trial management software (CTMS), or biobanking systems.  Download our Next Generation Biobanking whitepaper and learn about how to overcome the key challenges in clinical trial sample management from working in a distributed network of partners and stakeholder to managing consents and generating scientific insights.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement